Anthony C. Wood

Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma

Nur P. Damayanti, Justin A. Budka, Heba Khella et al. · Clinical Cancer Research · 2018 · 94 citations

Medicine, Cancer Biology, Oncology +13

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Veit Bücklein, Ariel Perez Perez, Kai Rejeski et al. · HemaSphere · 2023 · 35 citations · Full text

Medicine, Hematology, Oncology +17

Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis

Anthony C. Wood, Ariel Perez Perez, Brian Arciola et al. · Transplantation and Cellular Therapy · 2022 · 31 citations · Full text

Medicine, Immunology, Nephrology +11

Glucarpidase for treatment of high-dose methotrexate toxicity

Shruti Gupta, Sarah Allison Kaunfer, Kevin L. Chen et al. · Blood · 2025 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma

Anthony C. Wood, Saby George, Nabil Adra et al. · Investigational New Drugs · 2019 · 18 citations · Full text

Medicine, Oncology, Pharmacology +14